OTC · Medical - Diagnostics & Research

Imagion Biosystems Limited (IBXXF) Stock

$0.01 +0.00% OTC: IBXXF Healthcare

Imagion Biosystems Limited is dedicated to advancing medical imaging through innovative technologies centered on superparamagnetic relaxometry. The company's core mission is to enable the early detection of diseases, with a particular focus on cancer, and to monitor the efficacy of therapeutic interventions.

Valuation

MetricValue
Price$0.01
Market Cap$2.65M
P/E Ratio-0.83
P/B Ratio-2.19
P/S Ratio111.59
EPS (TTM)$-0.02
52-Week High$0.04
52-Week Low$0.01
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE142.99%
ROA-210.82%
ROCE192.71%
Gross Margin0.00%
Operating Margin-4990.16%
Net Margin0.00%
Debt/Equity-1.19
Current Ratio0.48

Annual Financials (USD)

Metric20212022202320242025
Revenue$3.0M$3.0M$5.0M$3.0M$0
Operating Profit$-8.0M$-12.0M$-16.0M$-1.0M$-4.0M
Net Profit$-6.0M$-10.0M$-12.0M$-2.0M$-4.0M
EPS$-0.24$-0.35$-0.41$-0.05$-0.02
Op Margin-291.2%-395.3%-318.1%-28.4%—

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$14.0M$10.0M$5.0M$3.0M$2.0M
Total Liabilities$1.0M$5.0M$8.0M$5.0M$4.0M
Cash$13.0M$4.0M$0$3.0M$2.0M
Borrowings$0$5.0M$6.0M$3.0M$3.0M

Latest News

Presenting on Emerging Growth Conference 93 Day 1 on June 10; Register to live stream GlobeNewswire · Jun 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-5.0M$-9.0M$-8.0M$-1.0M$-4.0M
Investing Cash Flow$-1.0M$-1.0M$0$0$0
Financing Cash Flow$0$0$-2.0M$0$0
Net Cash Flow$0$-9.0M$-4.0M$2.0M$-1.0M
Free Cash Flow$-5.0M$-9.0M$-9.0M$-1.0M$-4.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-1.01
FCF Yield-140.82%
Quick Ratio0.48
Interest Coverage-4.92
Return 1Y20.00%
Return 3Y-99.16%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AGNPFGrey Matters Health Inc. $0.25 -17.12% -0.43 $869804 0.00%
APLIFAppili Therapeutics Inc $0.01 +0.00% -0.44 $1.46M 0.00%
CSOCCaduceus Software Systems Corp. $0.00 — 0.36 $1.36M 0.00%
CSSICostas, Inc. $0.08 +122.22% -88.89 $1.86M 0.00%
GENPFGenix Pharmaceuticals Corporation $0.01 +0.00% -6.45 $844893 0.00%

About Imagion Biosystems Limited

Imagion Biosystems Limited is dedicated to advancing medical imaging through innovative technologies centered on superparamagnetic relaxometry. The company's core mission is to enable the early detection of diseases, with a particular focus on cancer, and to monitor the efficacy of therapeutic interventions. Its operational scope encompasses nanotechnology, biotechnology, and cancer diagnostics, all built upon its proprietary superparamagnetic relaxometry platform. Imagion's product pipeline includes MagSense, which is currently undergoing Phase I clinical trials for its application in HER2-positive breast cancer detection and management, as well as PrecisionMRX, an iron oxide nanoparticle engineered for general cancer detection. Imagion Biosystems also fosters strategic alliances, including a collaborative research program with Patrys Limited designed to integrate their respective technologies for improved imaging and diagnosis of brain tumors. Additionally, the company has a joint development agreement with Global Cancer Technology, Inc. to further develop GCT's novel nanoscintillator technology for the therapeutic treatment of breast cancer. The company was founded in 2016 and is headquartered in San Diego, California.

Imagion Biosystems Limited is headquartered in AU.

Imagion Biosystems Limited (IBXXF) stock trades at $0.01 with a market capitalization of $2.65M. The stock is valued at a price-to-earnings (P/E) ratio of -0.83, price-to-book of -2.19, price-to-sales of 111.59. Over the past 52 weeks the stock has ranged between $0.01 and $0.04, and currently trades 75.0% below its 52-week high.

On profitability, Imagion Biosystems Limited generates a return on equity (ROE) of 142.99% — well above the market average, a sign of a high-quality business, return on capital employed of 192.71%, an operating margin of -4990.16%, a net profit margin of 0.00%.

Official website: imagionbiosystems.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides